Change Language

Select Language

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

Liquid Biopsy Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Market Overview:

The global liquid biopsy market reached a value of US$ 1.49 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 3.7 Billion by 2027 exhibiting a CAGR of 15.70% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.

Liquid biopsy is a non-invasive alternative to surgical biopsies enabling doctors to obtain information about a tumor through a blood sample and plan the treatment accordingly. It can reflect changes in tumor gene expression profile and offer a robust base for individualized therapy. It assists in the early diagnosis screening, tumor heterogeneity and drug resistance. Besides this, it also detects epidermal growth factor receptor (EGFR) gene mutations, which occur among patients with non-small cell lung cancer (NSCLC).

 

 
 

www.imarcgroup.com

Note: Values and trends in the above chart consists of dummy data and are only shown here for representation purpose. Kindly contact us for the actual market size and trends.

To get more information about this market, Request Sample

Liquid Biopsy Market Trends:

Due to sedentary lifestyles and rising tobacco consumption, there is a surge in the number of cancer patients across the globe. This, along with the growing awareness among individuals about advanced minimally invasive (MI) procedures in cancer diagnostics, represents one of the key factors driving the market. Moreover, governing authorities of several countries are financing research and development (R&D) activities to encourage the introduction of advanced cancer solutions. These authorities are also considerable investing in the development of the healthcare industry, which is offering lucrative growth opportunities to industry players. Apart from this, key market players are focusing on product launches to develop personalized medicine worldwide. They are also integrating technological advancements in liquid biopsy to offer better procedure workflow and output. This, coupled with the rising adoption of blood-based biopsy tests for early tumor detection, is positively influencing the market. Additionally, the increasing usage of exosomes for clinical diagnosis in oncology to provide high accuracy and reduced procedural time is catalyzing the demand for liquid biopsy. Growth-inducing factors projected to impel the market growth are rapid development in digital polymerase chain reaction (PCR) and next-generation sequencing (NGS) based technology.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global liquid biopsy market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product and service, circulating biomarker, cancer type and end user.

Breakup by Product and Service:

 

 
 

www.imarcgroup.com

Note: Values and trends in the above chart consists of dummy data and are only shown here for representation purpose. Kindly contact us for the actual market size and trends.

To get more information about this market, Request Sample

  • Kits and Reagents
  • Platforms and Instruments
  • Services
     

Breakup by Circulating Biomarker:

  • Circulating Tumor Cells
  • Extracellular Vesicles
  • Circulating Tumor DNA
  • Others
     

Breakup by Cancer Type:

  • Lung Cancer
  • Breast Cancer
  • Colorectal Cancer
  • Prostate Cancer
  • Liver Cancer
  • Others  
     

Breakup by End User:

  • Hospitals and Laboratories
  • Academic and Research Centers
  • Others
     

Breakup by Region:

 

 
 

www.imarcgroup.com

To get more information on the regional analysis of this market, Request Sample

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being ANGLE plc, Biocept Inc., Bio-Rad Laboratories Inc, Epigenomics AG, Exact Sciences Corporation, F. Hoffmann-La Roche AG, Guardant Health Inc., Illumina Inc., MDxHealth SA, Menarini Silicon Biosystems, QIAGEN N.V. and Thermo Fisher Scientific Inc.

Report Coverage:

Report Features Details
Base Year of the Analysis 2021
    Historical Period 2016-2021
Forecast Period 2022-2027
Units US$ Billion
Segment Coverage Product and Service, Circulating Biomarker, Cancer Type, End User, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered ANGLE plc, Biocept Inc., Bio-Rad Laboratories Inc, Epigenomics AG, Exact Sciences Corporation, F. Hoffmann-La Roche AG, Guardant Health Inc., Illumina Inc., MDxHealth SA, Menarini Silicon Biosystems, QIAGEN N.V. and Thermo Fisher Scientific Inc.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

Key Questions Answered in This Report:

  • How has the global liquid biopsy market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global liquid biopsy market?
  • What are the key regional markets?
  • What is the breakup of the market based on the product and service?
  • What is the breakup of the market based on the circulating biomarker?
  • What is the breakup of the market based on the cancer type?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global liquid biopsy market and who are the key players?
  • What is the degree of competition in the industry?

1    Preface
2    Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction

    4.1    Overview
    4.2    Key Industry Trends
5    Global Liquid Biopsy Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6    Market Breakup by Product and Service
    6.1    Kits and Reagents
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Platforms and Instruments
        6.2.1 Market Trends
        6.2.2 Market Forecast
    6.3    Services
        6.3.1 Market Trends
        6.3.2 Market Forecast
7    Market Breakup by Circulating Biomarker
    7.1    Circulating Tumor Cells
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Extracellular Vesicles
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Circulating Tumor DNA
        7.3.1 Market Trends
        7.3.2 Market Forecast
    7.4    Others
        7.4.1 Market Trends
        7.4.2 Market Forecast
8    Market Breakup by Cancer Type
    8.1    Lung Cancer
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Breast Cancer
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Colorectal Cancer
        8.3.1 Market Trends
        8.3.2 Market Forecast
    8.4    Prostate Cancer
        8.4.1 Market Trends
        8.4.2 Market Forecast
    8.5    Liver Cancer
        8.5.1 Market Trends
        8.5.2 Market Forecast
    8.6    Others
        8.6.1 Market Trends
        8.6.2 Market Forecast
9    Market Breakup by End User
    9.1    Hospitals and Laboratories
        9.1.1 Market Trends
        9.1.2 Market Forecast
    9.2    Academic and Research Centers
        9.2.1 Market Trends
        9.2.2 Market Forecast
    9.3    Others
        9.3.1 Market Trends
        9.3.2 Market Forecast
10    Market Breakup by Region
    10.1    North America
        10.1.1 United States
           10.1.1.1 Market Trends
           10.1.1.2 Market Forecast
        10.1.2 Canada
           10.1.2.1 Market Trends
           10.1.2.2 Market Forecast
    10.2    Asia-Pacific
        10.2.1 China
           10.2.1.1 Market Trends
           10.2.1.2 Market Forecast
        10.2.2 Japan
           10.2.2.1 Market Trends
           10.2.2.2 Market Forecast
        10.2.3 India
           10.2.3.1 Market Trends
           10.2.3.2 Market Forecast
        10.2.4 South Korea
           10.2.4.1 Market Trends
           10.2.4.2 Market Forecast
        10.2.5 Australia
           10.2.5.1 Market Trends
           10.2.5.2 Market Forecast
        10.2.6 Indonesia
           10.2.6.1 Market Trends
           10.2.6.2 Market Forecast
        10.2.7 Others
           10.2.7.1 Market Trends
           10.2.7.2 Market Forecast
    10.3    Europe
        10.3.1 Germany
           10.3.1.1 Market Trends
           10.3.1.2 Market Forecast
        10.3.2 France
           10.3.2.1 Market Trends
           10.3.2.2 Market Forecast
        10.3.3 United Kingdom
           10.3.3.1 Market Trends
           10.3.3.2 Market Forecast
        10.3.4 Italy
           10.3.4.1 Market Trends
           10.3.4.2 Market Forecast
        10.3.5 Spain
           10.3.5.1 Market Trends
           10.3.5.2 Market Forecast
        10.3.6 Russia
           10.3.6.1 Market Trends
           10.3.6.2 Market Forecast
        10.3.7 Others
           10.3.7.1 Market Trends
           10.3.7.2 Market Forecast
    10.4    Latin America
        10.4.1 Brazil
           10.4.1.1 Market Trends
           10.4.1.2 Market Forecast
        10.4.2 Mexico
           10.4.2.1 Market Trends
           10.4.2.2 Market Forecast
        10.4.3 Others
           10.4.3.1 Market Trends
           10.4.3.2 Market Forecast
    10.5    Middle East and Africa
        10.5.1 Market Trends
        10.5.2 Market Breakup by Country
        10.5.3 Market Forecast
11    SWOT Analysis
    11.1    Overview
    11.2    Strengths
    11.3    Weaknesses
    11.4    Opportunities
    11.5    Threats
12    Value Chain Analysis
13    Porters Five Forces Analysis

    13.1    Overview
    13.2    Bargaining Power of Buyers
    13.3    Bargaining Power of Suppliers
    13.4    Degree of Competition
    13.5    Threat of New Entrants
    13.6    Threat of Substitutes
14    Price Analysis
15    Competitive Landscape

    15.1    Market Structure
    15.2    Key Players
    15.3    Profiles of Key Players
        15.3.1    ANGLE plc
           15.3.1.1 Company Overview
           15.3.1.2 Product Portfolio
           15.3.1.3 Financials
        15.3.2    Biocept Inc.
           15.3.2.1 Company Overview
           15.3.2.2 Product Portfolio
           15.3.2.3 Financials
        15.3.3    Bio-Rad Laboratories Inc
           15.3.3.1 Company Overview
           15.3.3.2 Product Portfolio
           15.3.3.3 Financials
           15.3.3.4 SWOT Analysis
        15.3.4    Epigenomics AG
           15.3.4.1 Company Overview
           15.3.4.2 Product Portfolio
           15.3.4.3 Financials
           15.3.4.4 SWOT Analysis
        15.3.5    Exact Sciences Corporation
           15.3.5.1 Company Overview
           15.3.5.2 Product Portfolio
           15.3.5.3 Financials
           15.3.5.4 SWOT Analysis
        15.3.6    F.Hoffmann-La Roche AG
           15.3.6.1 Company Overview
           15.3.6.2 Product Portfolio
           15.3.6.3 SWOT Analysis
        15.3.7    Guardant Health Inc.
           15.3.7.1 Company Overview
           15.3.7.2 Product Portfolio
           15.3.7.3 Financials
        15.3.8    Illumina Inc.
           15.3.8.1 Company Overview
           15.3.8.2 Product Portfolio
           15.3.8.3 Financials
           15.3.8.4 SWOT Analysis
        15.3.9    MDxHealth SA
           15.3.9.1 Company Overview
           15.3.9.2 Product Portfolio
           15.3.9.3 Financials
        15.3.10    Menarini Silicon Biosystems
           15.3.10.1 Company Overview
           15.3.10.2 Product Portfolio
        15.3.11    QIAGEN N.V.
           15.3.11.1 Company Overview
           15.3.11.2 Product Portfolio
           15.3.11.3 Financials
           15.3.11.4 SWOT Analysis
        15.3.12    Thermo Fisher Scientific Inc.
           15.3.12.1 Company Overview
           15.3.12.2 Product Portfolio
           15.3.12.3 Financials
           15.3.12.4 SWOT Analysis

List of Figures

Figure 1: Global: Liquid Biopsy Market: Major Drivers and Challenges
Figure 2: Global: Liquid Biopsy Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Liquid Biopsy Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Liquid Biopsy Market: Breakup by Product and Service (in %), 2021
Figure 5: Global: Liquid Biopsy Market: Breakup by Circulating Biomarker (in %), 2021
Figure 6: Global: Liquid Biopsy Market: Breakup by Cancer Type (in %), 2021
Figure 7: Global: Liquid Biopsy Market: Breakup by End User (in %), 2021
Figure 8: Global: Liquid Biopsy Market: Breakup by Region (in %), 2021
Figure 9: Global: Liquid Biopsy (Kits and Reagents) Market: Sales Value (in Million US$), 2016 & 2021
Figure 10: Global: Liquid Biopsy (Kits and Reagents) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 11: Global: Liquid Biopsy (Platforms and Instruments) Market: Sales Value (in Million US$), 2016 & 2021
Figure 12: Global: Liquid Biopsy (Platforms and Instruments) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 13: Global: Liquid Biopsy (Services) Market: Sales Value (in Million US$), 2016 & 2021
Figure 14: Global: Liquid Biopsy (Services) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 15: Global: Liquid Biopsy (Circulating Tumor Cells) Market: Sales Value (in Million US$), 2016 & 2021
Figure 16: Global: Liquid Biopsy (Circulating Tumor Cells) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 17: Global: Liquid Biopsy (Extracellular Vesicles) Market: Sales Value (in Million US$), 2016 & 2021
Figure 18: Global: Liquid Biopsy (Extracellular Vesicles) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 19: Global: Liquid Biopsy (Circulating Tumor DNA) Market: Sales Value (in Million US$), 2016 & 2021
Figure 20: Global: Liquid Biopsy (Circulating Tumor DNA) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 21: Global: Liquid Biopsy (Other Circulating Biomarkers) Market: Sales Value (in Million US$), 2016 & 2021
Figure 22: Global: Liquid Biopsy (Other Circulating Biomarkers) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 23: Global: Liquid Biopsy (Lung Cancer) Market: Sales Value (in Million US$), 2016 & 2021
Figure 24: Global: Liquid Biopsy (Lung Cancer) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 25: Global: Liquid Biopsy (Breast Cancer) Market: Sales Value (in Million US$), 2016 & 2021
Figure 26: Global: Liquid Biopsy (Breast Cancer) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 27: Global: Liquid Biopsy (Colorectal Cancer) Market: Sales Value (in Million US$), 2016 & 2021
Figure 28: Global: Liquid Biopsy (Colorectal Cancer) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 29: Global: Liquid Biopsy (Prostate Cancer) Market: Sales Value (in Million US$), 2016 & 2021
Figure 30: Global: Liquid Biopsy (Prostate Cancer) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 31: Global: Liquid Biopsy (Liver Cancer) Market: Sales Value (in Million US$), 2016 & 2021
Figure 32: Global: Liquid Biopsy (Liver Cancer) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 33: Global: Liquid Biopsy (Other Cancer Types) Market: Sales Value (in Million US$), 2016 & 2021
Figure 34: Global: Liquid Biopsy (Other Cancer Types) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 35: Global: Liquid Biopsy (Hospitals and Laboratories) Market: Sales Value (in Million US$), 2016 & 2021
Figure 36: Global: Liquid Biopsy (Hospitals and Laboratories) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 37: Global: Liquid Biopsy (Academic and Research Centers) Market: Sales Value (in Million US$), 2016 & 2021
Figure 38: Global: Liquid Biopsy (Academic and Research Centers) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 39: Global: Liquid Biopsy (Other End Users) Market: Sales Value (in Million US$), 2016 & 2021
Figure 40: Global: Liquid Biopsy (Other End Users) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 41: North America: Liquid Biopsy Market: Sales Value (in Million US$), 2016 & 2021
Figure 42: North America: Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 43: United States: Liquid Biopsy Market: Sales Value (in Million US$), 2016 & 2021
Figure 44: United States: Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 45: Canada: Liquid Biopsy Market: Sales Value (in Million US$), 2016 & 2021
Figure 46: Canada: Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 47: Asia-Pacific: Liquid Biopsy Market: Sales Value (in Million US$), 2016 & 2021
Figure 48: Asia-Pacific: Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 49: China: Liquid Biopsy Market: Sales Value (in Million US$), 2016 & 2021
Figure 50: China: Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 51: Japan: Liquid Biopsy Market: Sales Value (in Million US$), 2016 & 2021
Figure 52: Japan: Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 53: India: Liquid Biopsy Market: Sales Value (in Million US$), 2016 & 2021
Figure 54: India: Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 55: South Korea: Liquid Biopsy Market: Sales Value (in Million US$), 2016 & 2021
Figure 56: South Korea: Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 57: Australia: Liquid Biopsy Market: Sales Value (in Million US$), 2016 & 2021
Figure 58: Australia: Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 59: Indonesia: Liquid Biopsy Market: Sales Value (in Million US$), 2016 & 2021
Figure 60: Indonesia: Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 61: Others: Liquid Biopsy Market: Sales Value (in Million US$), 2016 & 2021
Figure 62: Others: Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 63: Europe: Liquid Biopsy Market: Sales Value (in Million US$), 2016 & 2021
Figure 64: Europe: Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 65: Germany: Liquid Biopsy Market: Sales Value (in Million US$), 2016 & 2021
Figure 66: Germany: Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 67: France: Liquid Biopsy Market: Sales Value (in Million US$), 2016 & 2021
Figure 68: France: Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 69: United Kingdom: Liquid Biopsy Market: Sales Value (in Million US$), 2016 & 2021
Figure 70: United Kingdom: Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 71: Italy: Liquid Biopsy Market: Sales Value (in Million US$), 2016 & 2021
Figure 72: Italy: Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 73: Spain: Liquid Biopsy Market: Sales Value (in Million US$), 2016 & 2021
Figure 74: Spain: Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 75: Russia: Liquid Biopsy Market: Sales Value (in Million US$), 2016 & 2021
Figure 76: Russia: Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 77: Others: Liquid Biopsy Market: Sales Value (in Million US$), 2016 & 2021
Figure 78: Others: Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 79: Latin America: Liquid Biopsy Market: Sales Value (in Million US$), 2016 & 2021
Figure 80: Latin America: Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 81: Brazil: Liquid Biopsy Market: Sales Value (in Million US$), 2016 & 2021
Figure 82: Brazil: Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 83: Mexico: Liquid Biopsy Market: Sales Value (in Million US$), 2016 & 2021
Figure 84: Mexico: Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 85: Others: Liquid Biopsy Market: Sales Value (in Million US$), 2016 & 2021
Figure 86: Others: Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 87: Middle East and Africa: Liquid Biopsy Market: Sales Value (in Million US$), 2016 & 2021
Figure 88: Middle East and Africa: Liquid Biopsy Market: Breakup by Country (in %), 2021
Figure 89: Middle East and Africa: Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 90: Global: Liquid Biopsy Industry: SWOT Analysis
Figure 91: Global: Liquid Biopsy Industry: Value Chain Analysis
Figure 92: Global: Liquid Biopsy Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Liquid Biopsy Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Liquid Biopsy Market Forecast: Breakup by Product and Service (in Million US$), 2022-2027
Table 3: Global: Liquid Biopsy Market Forecast: Breakup by Circulating Biomarker (in Million US$), 2022-2027
Table 4: Global: Liquid Biopsy Market Forecast: Breakup by Cancer Type (in Million US$), 2022-2027
Table 5: Global: Liquid Biopsy Market Forecast: Breakup by End User (in Million US$), 2022-2027
Table 6: Global: Liquid Biopsy Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 7: Global: Liquid Biopsy Market: Competitive Structure
Table 8: Global: Liquid Biopsy Market: Key Players


Note: We value your privacy and will never rent or sell your email address. Privacy policy

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Purchase Options




$ 2499

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )


Drop us an email at

sales@imarcgroup.com

Social Links